Tag: multiple diseases

HOW DO PUBLIC HEALTH INSTITUTIONS DECIDE WHICH HEALTH TECHNOLOGIES ARE AVAILABLE IN MEXICO?

Mexico City, Mexico – Since improving the process for the submission of new health technologies in 2011, the Mexican Public Health Institution has also optimized public resources through the use of technologies (supplies) that have proven their safety, therapeutic efficacy,

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , , , ,

THE IMPACT OF PRICE REDUCTIONS AND COST-SHARING RATES IN GREECE

Athens, Greece – Public expenditure on pharmaceuticals in Greece is high (compared to other EU countries) and has increased by 73%, from €3 billion in 2005 to €5.2 billion in 2009. Since 2010, cost containment efforts focused on the reduction

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , , ,

LOW INCOME DECREASES ADHERENCE TO MEDICATIONS

Beer-Sheva, Israel – Researchers from Ben-Gurion University of the Negev and Maccabi Healthcare Services, the second largest HMO in Israel, revealed that cost-related underuse of chronic pharmaceutical therapy is self-reported among approximately 10% of the chronically-ill patients. This phenomenon is strongly

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , , , ,

¿LA EVALUACIÓN DE INSUMOS, IMPACTA EN LA OPTIMIZACIÓN DE RECURSOS?

México, D.F. – En México, se fortaleció el proceso de actualización de medicamentos del  Cuadro Básico y Catálogo de Insumos del Sector Salud (CBCISS), estandarizando criterios de selección, basados en evidencia clínica-epidemiológica-económica. 

Posted in Health Policy Analyses, Value in Health Regional Issues Tagged with: , ,